The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
21 September 2021
Employment effect (start)
Foreseen end date
Description
Pharmaceutical company AstraZeneca is to create 100 new jobs in Dublin where it is to base a next-generation active pharmaceutical ingredient (API) manufacturing facility. The new plant will be located in Blanchardstown and will create 100 highly skilled jobs including scientists and engineers. The creation of further indirect jobs is also expected. This is AstraZeneca's first manufacturing plant in Ireland.
Eurofound (2021), AstraZeneca, Business expansion in Ireland, factsheet number 105271, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/105271.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
